PM
Publicaties op Oncologisch.com
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AM...
Behandeling Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and ...
FLAG-Ida plus GO bij AML: analyse
Quizartinib versus salvagechemotherapie bij recidief FLT3-ITD AML: QuANTUM-R fase III